Indolent lymphoma

The pathologist's viewpoint

S. A. Pileri, P. L. Zinzani, P. Went, A. Pileri, M. Bendandi

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Indolent lymphomas have recently been the object of numerous studies, which have focused on new aspects relevant both for the better comprehension of their histogenesis and the identification of new therapeutic strategies. As marginal-zone lymphoma (MZL) represents the category of indolent lymphomas that has obtained more benefit from such an approach, the authors focused on the most recent achievements and not yet solved controversies in this area. In spite of their postulated common derivation, the three categories of MZL of the WHO Classification appear dissimilar. In fact, they show significant molecular differences among them as well as a certain heterogeneity within each group. By no means, there is a cogent need of more refined tools to revise these neoplasms and to produce a more rational grouping. The recent identification of the IRTA gene family corresponding to IG-like receptors differentially expressed in B-cells might contribute to their better understanding.

Original languageEnglish
Pages (from-to)12-18
Number of pages7
JournalAnnals of Oncology
Volume15
Issue number1
DOIs
Publication statusPublished - Jan 2004

Fingerprint

Lymphoma
B-Lymphocytes
Pathologists
Genes
Neoplasms
Therapeutics

Keywords

  • Extranodal marginal zone lymphoma
  • Indolent lymphoma
  • Lymphoma classification
  • Nodal marginal zone lymphoma
  • Primary splenic marginal zone lymphoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Pileri, S. A., Zinzani, P. L., Went, P., Pileri, A., & Bendandi, M. (2004). Indolent lymphoma: The pathologist's viewpoint. Annals of Oncology, 15(1), 12-18. https://doi.org/10.1093/annonc/mdh002

Indolent lymphoma : The pathologist's viewpoint. / Pileri, S. A.; Zinzani, P. L.; Went, P.; Pileri, A.; Bendandi, M.

In: Annals of Oncology, Vol. 15, No. 1, 01.2004, p. 12-18.

Research output: Contribution to journalArticle

Pileri, SA, Zinzani, PL, Went, P, Pileri, A & Bendandi, M 2004, 'Indolent lymphoma: The pathologist's viewpoint', Annals of Oncology, vol. 15, no. 1, pp. 12-18. https://doi.org/10.1093/annonc/mdh002
Pileri, S. A. ; Zinzani, P. L. ; Went, P. ; Pileri, A. ; Bendandi, M. / Indolent lymphoma : The pathologist's viewpoint. In: Annals of Oncology. 2004 ; Vol. 15, No. 1. pp. 12-18.
@article{50311a3143164677957448616dc08ce9,
title = "Indolent lymphoma: The pathologist's viewpoint",
abstract = "Indolent lymphomas have recently been the object of numerous studies, which have focused on new aspects relevant both for the better comprehension of their histogenesis and the identification of new therapeutic strategies. As marginal-zone lymphoma (MZL) represents the category of indolent lymphomas that has obtained more benefit from such an approach, the authors focused on the most recent achievements and not yet solved controversies in this area. In spite of their postulated common derivation, the three categories of MZL of the WHO Classification appear dissimilar. In fact, they show significant molecular differences among them as well as a certain heterogeneity within each group. By no means, there is a cogent need of more refined tools to revise these neoplasms and to produce a more rational grouping. The recent identification of the IRTA gene family corresponding to IG-like receptors differentially expressed in B-cells might contribute to their better understanding.",
keywords = "Extranodal marginal zone lymphoma, Indolent lymphoma, Lymphoma classification, Nodal marginal zone lymphoma, Primary splenic marginal zone lymphoma",
author = "Pileri, {S. A.} and Zinzani, {P. L.} and P. Went and A. Pileri and M. Bendandi",
year = "2004",
month = "1",
doi = "10.1093/annonc/mdh002",
language = "English",
volume = "15",
pages = "12--18",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "1",

}

TY - JOUR

T1 - Indolent lymphoma

T2 - The pathologist's viewpoint

AU - Pileri, S. A.

AU - Zinzani, P. L.

AU - Went, P.

AU - Pileri, A.

AU - Bendandi, M.

PY - 2004/1

Y1 - 2004/1

N2 - Indolent lymphomas have recently been the object of numerous studies, which have focused on new aspects relevant both for the better comprehension of their histogenesis and the identification of new therapeutic strategies. As marginal-zone lymphoma (MZL) represents the category of indolent lymphomas that has obtained more benefit from such an approach, the authors focused on the most recent achievements and not yet solved controversies in this area. In spite of their postulated common derivation, the three categories of MZL of the WHO Classification appear dissimilar. In fact, they show significant molecular differences among them as well as a certain heterogeneity within each group. By no means, there is a cogent need of more refined tools to revise these neoplasms and to produce a more rational grouping. The recent identification of the IRTA gene family corresponding to IG-like receptors differentially expressed in B-cells might contribute to their better understanding.

AB - Indolent lymphomas have recently been the object of numerous studies, which have focused on new aspects relevant both for the better comprehension of their histogenesis and the identification of new therapeutic strategies. As marginal-zone lymphoma (MZL) represents the category of indolent lymphomas that has obtained more benefit from such an approach, the authors focused on the most recent achievements and not yet solved controversies in this area. In spite of their postulated common derivation, the three categories of MZL of the WHO Classification appear dissimilar. In fact, they show significant molecular differences among them as well as a certain heterogeneity within each group. By no means, there is a cogent need of more refined tools to revise these neoplasms and to produce a more rational grouping. The recent identification of the IRTA gene family corresponding to IG-like receptors differentially expressed in B-cells might contribute to their better understanding.

KW - Extranodal marginal zone lymphoma

KW - Indolent lymphoma

KW - Lymphoma classification

KW - Nodal marginal zone lymphoma

KW - Primary splenic marginal zone lymphoma

UR - http://www.scopus.com/inward/record.url?scp=0942266284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0942266284&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdh002

DO - 10.1093/annonc/mdh002

M3 - Article

VL - 15

SP - 12

EP - 18

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 1

ER -